Global Epigenetic Market 2024 by Company, Regions, Type and Application, Forecast to 2030

July 2024 | 101 pages | ID: G06D634A67C9EN
GlobalInfoResearch

Abstracts

According to our latest research, the global Epigenetic market size will reach USD 11230 million in 2030, growing at a CAGR of 7.1% over the analysis period.

Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.

The Epigenetic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.

Market segmentation

Epigenetic market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Reagents
• Kits
• Instruments
• Enzymes
• Services

Market segment by Application, can be divided into

• Academic Research Institutes
• Biotechnology Companies
• Biopharmaceutical Companies
• Diagnostic Companies

Market segment by players, this report covers

• Illumina
• Qiagen
• Abcam
• Merck & Co
• Sigma-Aldrich
• New England Biolabs
• Thermo Fisher Scientific
• Diagenode
• Active Motif
• Roche Diagnostics
• Eisai
• Novartis

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Epigenetic product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Epigenetic, with recent developments and future plans

Chapter 3, the Epigenetic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Epigenetic market forecast, by regions, with revenue, from 2024 to 2030.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.

Chapter 7 and 8, to describe Epigenetic research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Epigenetic
1.2 Classification of Epigenetic by Type
  1.2.1 Overview: Global Epigenetic Market Size by Type: 2024 Versus 2030
  1.2.2 Global Epigenetic Revenue Market Share by Type in 2030
  1.2.3 Reagents
  1.2.4 Kits
  1.2.5 Instruments
  1.2.6 Enzymes
  1.2.7 Services
1.3 Global Epigenetic Market by Application
  1.3.1 Overview: Global Epigenetic Market Size by Application: 2024 Versus 2030
  1.3.2 Academic Research Institutes
  1.3.3 Biotechnology Companies
  1.3.4 Biopharmaceutical Companies
  1.3.5 Diagnostic Companies
1.4 Global Epigenetic Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Epigenetic Market Drivers
  1.5.2 Epigenetic Market Restraints
  1.5.3 Epigenetic Trends Analysis

2 COMPANY PROFILES

2.1 Illumina
  2.1.1 Illumina Details
  2.1.2 Illumina Major Business
  2.1.3 Illumina Epigenetic Product and Solutions
  2.1.4 Illumina Recent Developments and Future Plans
2.2 Qiagen
  2.2.1 Qiagen Details
  2.2.2 Qiagen Major Business
  2.2.3 Qiagen Epigenetic Product and Solutions
  2.2.4 Qiagen Recent Developments and Future Plans
2.3 Abcam
  2.3.1 Abcam Details
  2.3.2 Abcam Major Business
  2.3.3 Abcam Epigenetic Product and Solutions
  2.3.4 Abcam Recent Developments and Future Plans
2.4 Merck & Co
  2.4.1 Merck & Co Details
  2.4.2 Merck & Co Major Business
  2.4.3 Merck & Co Epigenetic Product and Solutions
  2.4.4 Merck & Co Recent Developments and Future Plans
2.5 Sigma-Aldrich
  2.5.1 Sigma-Aldrich Details
  2.5.2 Sigma-Aldrich Major Business
  2.5.3 Sigma-Aldrich Epigenetic Product and Solutions
  2.5.4 Sigma-Aldrich Recent Developments and Future Plans
2.6 New England Biolabs
  2.6.1 New England Biolabs Details
  2.6.2 New England Biolabs Major Business
  2.6.3 New England Biolabs Epigenetic Product and Solutions
  2.6.4 New England Biolabs Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
  2.7.1 Thermo Fisher Scientific Details
  2.7.2 Thermo Fisher Scientific Major Business
  2.7.3 Thermo Fisher Scientific Epigenetic Product and Solutions
  2.7.4 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Diagenode
  2.8.1 Diagenode Details
  2.8.2 Diagenode Major Business
  2.8.3 Diagenode Epigenetic Product and Solutions
  2.8.4 Diagenode Recent Developments and Future Plans
2.9 Active Motif
  2.9.1 Active Motif Details
  2.9.2 Active Motif Major Business
  2.9.3 Active Motif Epigenetic Product and Solutions
  2.9.4 Active Motif Recent Developments and Future Plans
2.10 Roche Diagnostics
  2.10.1 Roche Diagnostics Details
  2.10.2 Roche Diagnostics Major Business
  2.10.3 Roche Diagnostics Epigenetic Product and Solutions
  2.10.4 Roche Diagnostics Recent Developments and Future Plans
2.11 Eisai
  2.11.1 Eisai Details
  2.11.2 Eisai Major Business
  2.11.3 Eisai Epigenetic Product and Solutions
  2.11.4 Eisai Recent Developments and Future Plans
2.12 Novartis
  2.12.1 Novartis Details
  2.12.2 Novartis Major Business
  2.12.3 Novartis Epigenetic Product and Solutions
  2.12.4 Novartis Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Epigenetic Revenue and Share by Players (2024 & 2030)
3.2 Epigenetic Players Head Office, Products and Services Provided
3.3 Epigenetic Mergers & Acquisitions
3.4 Epigenetic New Entrants and Expansion Plans

4 GLOBAL EPIGENETIC FORECAST BY REGION

4.1 Global Epigenetic Market Size by Region: 2024 VS 2030
4.2 Global Epigenetic Market Size by Region, (2024-2030)
4.3 North America
  4.3.1 Key Companies of Epigenetic in North America
  4.3.2 Current Situation and Forecast of Epigenetic in North America
  4.3.3 North America Epigenetic Market Size and Prospect (2024-2030)
4.4 Europe
  4.4.1 Key Companies of Epigenetic in Europe
  4.4.2 Current Situation and Forecast of Epigenetic in Europe
  4.4.3 Europe Epigenetic Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
  4.5.1 Key Companies of Epigenetic in Asia-Pacific
  4.5.2 Current Situation and Forecast of Epigenetic in Asia-Pacific
  4.5.3 Asia-Pacific Epigenetic Market Size and Prospect (2024-2030)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Epigenetic in South America
  4.6.2 Current Situation and Forecast of Epigenetic in South America
  4.6.3 South America Epigenetic Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
  4.7.1 Key Companies of Epigenetic in Middle East & Africa
  4.7.2 Current Situation and Forecast of Epigenetic in Middle East & Africa
  4.7.3 Middle East & Africa Epigenetic Market Size and Prospect (2024-2030)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Epigenetic Market Forecast by Type (2024-2030)
5.2 Global Epigenetic Market Share Forecast by Type (2024-2030)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Epigenetic Market Forecast by Application (2024-2030)
6.2 Global Epigenetic Market Share Forecast by Application (2024-2030)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Epigenetic Revenue by Type, (USD Million), 2024 VS 2030
Table 2. Global Epigenetic Revenue by Application, (USD Million), 2024 VS 2030
Table 3. Illumina Corporate Information, Head Office, and Major Competitors
Table 4. Illumina Major Business
Table 5. Illumina Epigenetic Product and Solutions
Table 6. Qiagen Corporate Information, Head Office, and Major Competitors
Table 7. Qiagen Major Business
Table 8. Qiagen Epigenetic Product and Solutions
Table 9. Abcam Corporate Information, Head Office, and Major Competitors
Table 10. Abcam Major Business
Table 11. Abcam Epigenetic Product and Solutions
Table 12. Merck & Co Corporate Information, Head Office, and Major Competitors
Table 13. Merck & Co Major Business
Table 14. Merck & Co Epigenetic Product and Solutions
Table 15. Sigma-Aldrich Corporate Information, Head Office, and Major Competitors
Table 16. Sigma-Aldrich Major Business
Table 17. Sigma-Aldrich Epigenetic Product and Solutions
Table 18. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 19. New England Biolabs Major Business
Table 20. New England Biolabs Epigenetic Product and Solutions
Table 21. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 22. Thermo Fisher Scientific Major Business
Table 23. Thermo Fisher Scientific Epigenetic Product and Solutions
Table 24. Diagenode Corporate Information, Head Office, and Major Competitors
Table 25. Diagenode Major Business
Table 26. Diagenode Epigenetic Product and Solutions
Table 27. Active Motif Corporate Information, Head Office, and Major Competitors
Table 28. Active Motif Major Business
Table 29. Active Motif Epigenetic Product and Solutions
Table 30. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Roche Diagnostics Major Business
Table 32. Roche Diagnostics Epigenetic Product and Solutions
Table 33. Eisai Corporate Information, Head Office, and Major Competitors
Table 34. Eisai Major Business
Table 35. Eisai Epigenetic Product and Solutions
Table 36. Novartis Corporate Information, Head Office, and Major Competitors
Table 37. Novartis Major Business
Table 38. Novartis Epigenetic Product and Solutions
Table 39. Global Epigenetic Revenue (USD Million) by Players (2024 & 2030)
Table 40. Global Epigenetic Revenue Share by Players (2024 & 2030)
Table 41. Epigenetic Players Head Office, Products and Services Provided
Table 42. Epigenetic Mergers & Acquisitions in the Past Five Years
Table 43. Epigenetic New Entrants and Expansion Plans
Table 44. Global Market Epigenetic Revenue (USD Million) Comparison by Region (2024 VS 2030)
Table 45. Global Epigenetic Revenue Market Share by Region (2024-2030)
Table 46. Key Companies of Epigenetic in North America
Table 47. Current Situation and Forecast of Epigenetic in North America
Table 48. Key Companies of Epigenetic in Europe
Table 49. Current Situation and Forecast of Epigenetic in Europe
Table 50. Key Companies of Epigenetic in Asia-Pacific
Table 51. Current Situation and Forecast of Epigenetic in Asia-Pacific
Table 52. Key Companies of Epigenetic in China
Table 53. Key Companies of Epigenetic in Japan
Table 54. Key Companies of Epigenetic in South Korea
Table 55. Key Companies of Epigenetic in South America
Table 56. Current Situation and Forecast of Epigenetic in South America
Table 57. Key Companies of Epigenetic in Middle East & Africa
Table 58. Current Situation and Forecast of Epigenetic in Middle East & Africa
Table 59. Global Epigenetic Revenue Forecast by Type (2024-2030)
Table 60. Global Epigenetic Revenue Forecast by Application (2024-2030)

List Of Figures

LIST OF FIGURES

Figure 1. Epigenetic Picture
Figure 2. Global Epigenetic Revenue Market Share by Type in 2030
Figure 3. Reagents
Figure 4. Kits
Figure 5. Instruments
Figure 6. Enzymes
Figure 7. Services
Figure 8. Epigenetic Revenue Market Share by Application in 2030
Figure 9. Academic Research Institutes Picture
Figure 10. Biotechnology Companies Picture
Figure 11. Biopharmaceutical Companies Picture
Figure 12. Diagnostic Companies Picture
Figure 13. Global Epigenetic Market Size, (USD Million): 2024 VS 2030
Figure 14. Global Epigenetic Revenue and Forecast (2024-2030) & (USD Million)
Figure 15. Epigenetic Market Drivers
Figure 16. Epigenetic Market Restraints
Figure 17. Epigenetic Market Trends
Figure 18. Illumina Recent Developments and Future Plans
Figure 19. Qiagen Recent Developments and Future Plans
Figure 20. Abcam Recent Developments and Future Plans
Figure 21. Merck & Co Recent Developments and Future Plans
Figure 22. Sigma-Aldrich Recent Developments and Future Plans
Figure 23. New England Biolabs Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Diagenode Recent Developments and Future Plans
Figure 26. Active Motif Recent Developments and Future Plans
Figure 27. Roche Diagnostics Recent Developments and Future Plans
Figure 28. Eisai Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Global Epigenetic Revenue Market Share by Region (2024-2030)
Figure 31. Global Epigenetic Revenue Market Share by Region in 2030
Figure 32. North America Epigenetic Revenue (USD Million) and Growth Rate (2024-2030)
Figure 33. Europe Epigenetic Revenue (USD Million) and Growth Rate (2024-2030)
Figure 34. Asia-Pacific Epigenetic Revenue (USD Million) and Growth Rate (2024-2030)
Figure 35. South America Epigenetic Revenue (USD Million) and Growth Rate (2024-2030)
Figure 36. Middle East & Africa Epigenetic Revenue (USD Million) and Growth Rate (2024-2030)
Figure 37. Global Epigenetic Market Share Forecast by Type (2024-2030)
Figure 38. Global Epigenetic Market Share Forecast by Application (2024-2030)
Figure 39. Methodology
Figure 40. Research Process and Data Source